Publications by the researcher in collaboration with Francisco Javier Pavón Morón (113)

2026

  1. Developmental Timing of Alcohol Initiation as a Marker of Adult Clinical Complexity in Alcohol Use Disorder: A Cross-Sectional Study

    Medical sciences, Vol. 14, Núm. 5

2025

  1. Exploratory study on plasma Acylglycerol and Acylethanolamide dysregulation in substance use and attention-deficit/hyperactivity disorder: Implications for novel biomarkers in dual diagnosis

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 138

  2. Sex differences in the comorbidity of patients seeking a first treatment for Alcohol Use Disorder

    International Journal of Mental Health and Addiction, Vol. 23, Núm. 1, pp. 1-15

  3. Sex-specific dysregulation of the CX3CL1/CX3CR1 Axis following cocaine exposure: Translational evidence for a potential biomarker of abstinence

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 141

2024

  1. Correction: Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders(Translational Psychiatry, 10.1038/s41398-023-02523-1)

    Translational Psychiatry

  2. Dysregulation of Plasma Growth Factors and Chemokines in Cocaine Use Disorder: Implications for Dual Diagnosis with Schizophrenia and Antisocial Personality Disorder in an Exploratory Study

    Neuropsychobiology, Vol. 83, Núm. 2, pp. 73-88

2023

  1. Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

  2. Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder

    International journal of molecular sciences, Vol. 24, Núm. 11

  3. Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  4. Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

  5. Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders

    Translational Psychiatry, Vol. 13, Núm. 1

  6. Sex differences in the comorbidity of patients seeking a first treatment for Alcohol Use Disorder

    International Journal of Mental Health and Addiction

2021

  1. Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinking

    Addiction Biology, Vol. 26, Núm. 3

  2. Sex-specific behavioral and neurogenic responses to cocaine in mice lacking and blocking dopamine D1 or dopamine D2 receptors

    Journal of Comparative Neurology, Vol. 529, Núm. 8, pp. 1724-1742

  3. Sudden cessation of fluoxetine before alcohol drinking reinstatement alters microglial morphology and TLR4/inflammatory neuroadaptation in the rat brain

    Brain Structure and Function, Vol. 226, Núm. 7, pp. 2243-2264

2020

  1. Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases

    Journal of Psychopharmacology, Vol. 34, Núm. 11, pp. 1250-1260

  2. COX-2 Inhibition Antagonizes Intra-Accumbens 2-Arachidonoylglycerol–Mediated Reduction in Ethanol Self-Administration in Rats

    Alcoholism: Clinical and Experimental Research, Vol. 44, Núm. 11, pp. 2158-2165

  3. Cocaine-induced changes in CX3CL1 and inflammatory signaling pathways in the hippocampus: Association with IL1β

    Neuropharmacology, Vol. 162

  4. D-pinitol from ceratonia siliqua is an orally active natural inositol that reduces pancreas insulin secretion and increases circulating ghrelin levels in wistar rats

    Nutrients, Vol. 12, Núm. 7, pp. 1-22

  5. Differential hepatoprotective role of the cannabinoid CB1 and CB2 receptors in paracetamol-induced liver injury

    British Journal of Pharmacology, Vol. 177, Núm. 14, pp. 3309-3326